Stroud Sarah, Katyal Toshali, Gornitzky Alex L, Swarup Ishaan
Department of Orthopaedic Surgery, University of California, San Francisco, San Francisco, CA 94143, United States.
Department of Orthopaedic Surgery, University of California, San Francisco Benioff Children's Hospital, San Francisco, CA 94143, United States.
World J Orthop. 2022 May 18;13(5):494-502. doi: 10.5312/wjo.v13.i5.494.
Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly prescribed medications in the United States. Although they are safe and effective means of analgesia for children with broken bones, there is considerable variation in their clinical use due to persistent concerns about their potentially adverse effect on fracture healing.
To assess whether NSAID exposure is a risk factor for fracture nonunion in children.
We systematically reviewed the literature reporting the effect of NSAIDs on bone healing. We included all clinical studies that reported on adverse bone healing complications in children with respect to NSAID exposure. The outcomes of interest were delayed union or nonunion. Study quality was assessed using the Newcastle-Ottawa scale for non-randomized studies. A final table was constructed summarizing the available evidence.
A total of 120 articles were identified and screened, of which 6 articles were included for final review. Nonunion in children is extremely rare; among the studies included, there were 2011 nonunions among 238822 fractures (0.84%). None of the included studies documented an increased risk of nonunion or delayed bone healing in those children who are treated with NSAIDs in the immediate post-injury or peri-operative time period. Additionally, children are likely to take these medications for only a few days after injury or surgery, further decreasing their risk of adverse side-effects.
This systematic review suggests that NSAIDS can be safely prescribed to pediatric orthopaedic patients absent other contraindications without concern for increased risk of fracture non-union or delayed bone healing. Additional prospective studies are needed focusing on higher risk fractures and elective orthopaedic procedures such as osteotomies and spinal fusion.
非甾体抗炎药(NSAIDs)是美国最常用的处方药之一。尽管它们是治疗骨折儿童的安全有效的镇痛方法,但由于人们一直担心其对骨折愈合可能产生的不良影响,其临床应用存在很大差异。
评估NSAIDs暴露是否是儿童骨折不愈合的危险因素。
我们系统地回顾了报告NSAIDs对骨愈合影响的文献。我们纳入了所有报告NSAIDs暴露对儿童骨愈合不良并发症影响的临床研究。感兴趣的结果是延迟愈合或不愈合。使用纽卡斯尔-渥太华量表评估非随机研究的研究质量。构建了一个最终表格,总结了现有证据。
共识别和筛选了120篇文章,其中6篇文章纳入最终综述。儿童骨折不愈合极为罕见;在纳入的研究中,238822例骨折中有2011例不愈合(0.84%)。纳入的研究均未记录在伤后即刻或围手术期接受NSAIDs治疗的儿童中,不愈合或骨愈合延迟的风险增加。此外,儿童在受伤或手术后可能只服用几天这些药物,进一步降低了其出现副作用的风险。
这项系统综述表明,在没有其他禁忌症的情况下,可以安全地为小儿骨科患者开具NSAIDs,而无需担心骨折不愈合或骨愈合延迟的风险增加。需要开展更多前瞻性研究,重点关注高风险骨折以及截骨术和脊柱融合等择期骨科手术。